Given that cGAS hyperactivation can trigger autoimmune diseases such as AGS, we found that KDM4B deficiency or its inhibitor JIB-04 significantly suppresses cGAS activation and IFN expression, providing a novel therapeutic target and strategy for autoimmune diseases. Here, KDM4B is linked to autoimmune disease.